CAMFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor
Condition: Desmoplastic Small Round Cell Tumor Interventions: Drug: Ramucirumab; Drug: Cyclophosphamide; Drug: Vinorelbine Sponsor: Eli Lilly and Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials